Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram

Journal of Sex and Marital Therapy

Volumn 31, Issue 3, 2005, Pages 257-262

  Ashton, Adam Keller ^a,b   Mahmood, Ahsan ^a   Iqbal, Farhan ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHOICE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PSYCHOPHARMACOTHERAPY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT SATISFACTION; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 17844401706     PISSN: 0092623X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00926230590513474     Document Type: Article

References (9)

1. Ashton, A. K. (2004). Reversal of fluoxetine-induced sexual dysfunction by switching to escitalopram. Journal of Sex & Marital Therapy, 30, 1-2.
2. Ashton, A. K., & Rosen, R. C. (1998). Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. Journal of Sex & Marital Therapy, 24, 191-192.
3. Ashton, A. K., Young, C. M., & LoPiccolo, J. (2001). Premature ejaculation and male orgasmic disorder. In G. O. Gabbard (Ed.), Treatments of psychiatric disorders (3rd ed., 1911-1933). Washington, D.C.: APA Press.
4. Balon, R. (1995). The effects of antidepressants on human sexuality: Diagnosis and management. Primary Psychiatry, 2, 46-51.
5. Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. L, Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002). Prevalence of sexual dysfunction among newer antidepressants. Journal of Clinical Psychiatry, 63, 357-366.
6. Coleman, C. C., Cunningham, L. A., Foster, V. J., Batey, S. R., Donahue, R. M. J., Houser, T. L., & Ascher, J. A. (1999). Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment. Annals of Clinical Psychiatry, 11, 205-215.
7. Croft, H., Settle, E., Houser, T., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999). A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-released bupropion and sertraline. Clinical Therapeutics, 21, 643-648.
8. Jamerson, B., Ashton, A. K., Houser, T. L., Leadbetter, R. A., Wagoner, C., & Metz, A. (2001). Antidepressant compliance and side effects: Results from a patient survey. Paper presented at the annual meeting of the American Psychiatric Association, May, New Orleans, LA.
9. Montejo-Gonzalez, A. M., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudid, J., Daniel, E., De La Gandara, J., Derecho, J., Franco, M., Gomez, M. J., Macias, J. A., Martin, T., Perez, V., Sanchez, J. M., Sanchez, S., & Vicens, E. (1997). SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective multicenter and descriptive clinical study of 344 patients. Journal of Sex & Marital Therapy, 23, 176-194.